Ilse Roodink

407 total citations
9 papers, 330 citations indexed

About

Ilse Roodink is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ilse Roodink has authored 9 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ilse Roodink's work include Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Ilse Roodink is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Ilse Roodink collaborates with scholars based in Netherlands, Finland and United States. Ilse Roodink's co-authors include William P. J. Leenders, Jos Raats, Kiek Verrijp, Kiek Verrijp, Benno Küsters, Robert M.W. de Waal, Cathy Maass, Pieter Wesseling, Jeroen van der Laak and Dorien M. Tiemessen and has published in prestigious journals such as Cancer Research, Oncogene and American Journal Of Pathology.

In The Last Decade

Ilse Roodink

9 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilse Roodink Netherlands	9	181	106	102	97	80	9	330
Laura A Strickland France	4	225 1.2×	132 1.2×	92 0.9×	64 0.7×	33 0.4×	5	340
Gabriele Foos United States	5	315 1.7×	105 1.0×	160 1.6×	46 0.5×	93 1.2×	5	438
Isis C. Sroka United States	10	150 0.8×	114 1.1×	31 0.3×	80 0.8×	44 0.6×	12	342
Laura Nogués Spain	9	308 1.7×	88 0.8×	60 0.6×	85 0.9×	32 0.4×	12	381
Yi-Ying Wu Taiwan	8	384 2.1×	179 1.7×	79 0.8×	219 2.3×	38 0.5×	8	556
Gloria V. Echeverria United States	9	239 1.3×	107 1.0×	74 0.7×	104 1.1×	19 0.2×	19	357
Won‐Sik Shin South Korea	13	432 2.4×	185 1.7×	28 0.3×	75 0.8×	70 0.9×	20	575
Wenliang Li China	12	259 1.4×	88 0.8×	39 0.4×	103 1.1×	62 0.8×	27	423
Melinda D. Willard United States	15	306 1.7×	144 1.4×	59 0.6×	42 0.4×	49 0.6×	27	478
Hanna Heloterä Finland	7	302 1.7×	225 2.1×	46 0.5×	43 0.4×	123 1.5×	13	478

Countries citing papers authored by Ilse Roodink

Since Specialization

Citations

This map shows the geographic impact of Ilse Roodink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Roodink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Roodink more than expected).

Fields of papers citing papers by Ilse Roodink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse Roodink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Roodink. The network helps show where Ilse Roodink may publish in the future.

Co-authorship network of co-authors of Ilse Roodink

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse Roodink. A scholar is included among the top collaborators of Ilse Roodink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse Roodink. Ilse Roodink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lith, Sanne A. M. van, Ilse Roodink, Joost J.C. Verhoeff, et al.. (2016). In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued. Oncotarget. 7(44). 71594–71607. 10 indexed citations

Roodink, Ilse & William P. J. Leenders. (2010). Targeted therapies of cancer: Angiogenesis inhibition seems not enough. Cancer Letters. 299(1). 1–10. 48 indexed citations

Kats‐Ugurlu, Gürsah, Ilse Roodink, Dorien M. Tiemessen, et al.. (2009). Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma. The Journal of Pathology. 219(3). 287–293. 63 indexed citations

Roodink, Ilse, et al.. (2009). Isolation of targeting nanobodies against co-opted tumor vasculature. Laboratory Investigation. 90(1). 61–67. 12 indexed citations

Roodink, Ilse, Kiek Verrijp, Jos Raats, & William P. J. Leenders. (2009). Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. BMC Cancer. 9(1). 297–297. 35 indexed citations

Roodink, Ilse, Léon C.L.T. van Kempen, Cathy Maass, et al.. (2008). Semaphorin 3E Expression Correlates Inversely with Plexin D1 During Tumor Progression. American Journal Of Pathology. 173(6). 1873–1881. 42 indexed citations

Küsters, Benno, Ilse Roodink, Kiek Verrijp, et al.. (2007). Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis. Oncogene. 26(39). 5808–5815. 43 indexed citations

Roodink, Ilse, Jeroen van der Laak, Benno Küsters, et al.. (2006). Development of the tumor vascular bed in response to hypoxia‐induced VEGF‐A differs from that in tumors with constitutive VEGF‐A expression. International Journal of Cancer. 119(9). 2054–2062. 24 indexed citations

Roodink, Ilse, Jos Raats, Bert van der Zwaag, et al.. (2005). Plexin D1 Expression Is Induced on Tumor Vasculature and Tumor Cells: A Novel Target for Diagnosis and Therapy?. Cancer Research. 65(18). 8317–8323. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact